RHENMAN & PARTNERS ASSET MANAGEMENT AB Iovance Biotherapeutics, Inc. Transaction History

RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:

$4.76M
portfolio value

RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:

-13.22%
quarter

Iovance Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -3.77% -20K shares -1.08M $9.58 510K
Q2 2022 share Increase +11.58% 55K shares -2.05M $11.04 530K
Q1 2022 share Decrease -20.83% -125K shares -3.74M $16.65 475K
Q4 2021 share Increase +87.50% 280K shares 3.76M $19.42 600K
Q3 2021 share Increase +6.67% 20K shares 85K $24.66 320K
Q2 2021 share Increase +1.69% 5K shares -1.53M $26.02 300K
Q1 2021 share Decrease -7.81% -25K shares -5.50M $31.66 295K
Q4 2020 share Decrease -5.88% -20K shares 3.65M $46.4 320K
Q3 2020 share 0.00% 0 shares 1.86M $32.92 340K
Q2 2020 share Decrease -6.85% -25K shares -1.59M $27.45 340K
Q1 2020 share Decrease -23.16% -110K shares -2.22M $29.94 365K
Q4 2019 share Decrease -8.65% -45K shares 3.68M $27.68 475K
Q3 2019 share Decrease -30.73% -230.7K shares -8.94M $18.2 520K
Q2 2019 share Decrease -14.65% -128.9K shares 10.04M $24.52 750.7K
Q1 2019 share Decrease -27.03% -325.89K shares -2.30M $9.51 879.6K
Q4 2018 share Decrease -6.59% -85K shares -3.84M $8.85 1.20M
Q3 2018 share Increase +52.28% 443.01K shares 3.67M $11.25 1.29M
Q2 2018 share Decrease -10.24% -96.70K shares -5.10M $12.8 847.47K
Q1 2018 share 0.00% 0 shares 8.40M $16.9 944.18K
Q4 2017 share Increase +32.77% 233.02K shares 2.04M $8 944.18K
Q3 2017 share Increase +9.41% 61.16K shares 734K $7.75 711.16K
Q2 2017 share Increase 0.00% 650K shares 4.77M $7.35 650K